Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Aβ immunotherapy

被引:10
作者
Das, Pritam [1 ]
Smithson, Lisa A. [1 ]
Price, Robert W. [1 ]
Holloway, Vallie M. [1 ]
Levites, Yona [1 ]
Chakrabarty, Paramita [1 ]
Golde, Todd E. [1 ]
机构
[1] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
D O I
10.1186/1742-2094-3-17
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Microglial activation has been proposed to facilitate clearance of amyloid beta protein (A beta) from the brain following A beta immunotherapy in amyloid precursor protein (APP) transgenic mice. Interleukin-1 receptor 1 knockout (IL-1 R1-/-) mice are reported to exhibit blunted inflammatory responses to injury. To further define the role of IL-1-mediated inflammatory responses and microglial activation in this paradigm, we examined the efficacy of passive A beta immunotherapy in Tg2576 mice crossed into the IL-1 R1-/-background. In addition, we examined if loss of IL-1 R1-/-modifies A beta deposition in the absence of additional manipulations. Methods: We passively immunized Tg2576 mice crossed into the IL-1 R1-/-background (APP/IL-1 R1-/-mice) with an anti-A beta 1-16 mAb (mAb9, IgG2a) that we previously showed could attenuate A beta deposition in Tg2576 mice. We also examined whether the IL-1 R1 knockout background modifies A beta deposition in untreated mice. Biochemical and immunohistochemical A beta loads and microglial activation was assessed. Results: Passive immunization with anti-A beta mAb was effective in reducing plaque load in APP/IL-1 R1-/-mice when the immunization was started prior to significant plaque deposition. Similar to previous studies, immunization was not effective in older APP/IL-1 R1-/-mice or IL-1 R1 sufficient wild type Tg2576 mice. Our analysis of A beta deposition in the untreated APP/IL-1 R1-/-mice did not show differences on biochemical A beta loads during normal aging of these mice compared to IL-1 R1 sufficient wild type Tg2576 mice. Conclusion: We find no evidence that the lack of the IL-1 R1 receptor influences either A beta deposition or the efficacy of passive immunotherapy. Such results are consistent with other studies in Tg2576 mice that suggest microglial activation may not be required for efficacy in passive immunization approaches.
引用
收藏
页数:13
相关论文
共 59 条
[1]   Specificity of mechanisms for plaque removal after Aβ immunotherapy for Alzheimer disease [J].
Akiyama, H ;
McGeer, PL .
NATURE MEDICINE, 2004, 10 (02) :117-118
[2]  
Bacskai BJ, 2002, J NEUROSCI, V22, P7873
[3]   Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease [J].
Bard, F ;
Cannon, C ;
Barbour, R ;
Burke, RL ;
Games, D ;
Grajeda, H ;
Guido, T ;
Hu, K ;
Huang, JP ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, M ;
Lieberburg, I ;
Motter, R ;
Nguyen, M ;
Soriano, F ;
Vasquez, N ;
Weiss, K ;
Welch, B ;
Seubert, P ;
Schenk, D ;
Yednock, T .
NATURE MEDICINE, 2000, 6 (08) :916-919
[4]   Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology [J].
Bard, F ;
Barbour, R ;
Cannon, C ;
Carretto, R ;
Fox, M ;
Games, D ;
Guido, T ;
Hoenow, K ;
Hu, K ;
Johnson-Wood, K ;
Khan, K ;
Kholodenko, D ;
Lee, C ;
Lee, M ;
Motter, R ;
Nguyen, M ;
Reed, A ;
Schenk, D ;
Tang, P ;
Vasquez, N ;
Seubert, P ;
Yednock, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :2023-2028
[5]  
Basu A, 2002, J NEUROSCI, V22, P6071
[6]   Evidence for glial-mediated inflammation in aged APPSW transgenic mice [J].
Benzing, WC ;
Wujek, JR ;
Ward, EK ;
Shaffer, D ;
Ashe, KH ;
Younkin, SG ;
Brunden, KR .
NEUROBIOLOGY OF AGING, 1999, 20 (06) :581-589
[7]   Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice [J].
Brendza, RP ;
Bacskai, BJ ;
Cirrito, JR ;
Simmons, KA ;
Skoch, JM ;
Klunk, WE ;
Mathis, CA ;
Bales, KR ;
Paul, SM ;
Hyman, BT ;
Holtzman, DM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :428-433
[8]   Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid β peptide [J].
Chen, KQ ;
Iribarren, P ;
Hu, JY ;
Chen, JH ;
Gong, WH ;
Cho, EH ;
Lockett, S ;
Dunlop, NM ;
Wang, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (06) :3651-3659
[9]   INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4 [J].
COLOTTA, F ;
RE, F ;
MUZIO, M ;
BERTINI, R ;
POLENTARUTTI, N ;
SIRONI, M ;
GIRI, JG ;
DOWER, SK ;
SIMS, JE ;
MANTOVANI, A .
SCIENCE, 1993, 261 (5120) :472-475
[10]   Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid [J].
Craft, Jeffrey M. ;
Watterson, D. Martin ;
Hirsch, Emmet ;
Van Eldik, Linda J. .
JOURNAL OF NEUROINFLAMMATION, 2005, 2 (1)